A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Active, not recruiting · NCT05956626 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-31 | NCT05956626 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ocugen | 6 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advanced Research, LLC | Pompano Beach | United States | 1 |
| Associated Retina Consultants | Phoenix | United States | 21 |
| Bascom Palmer Eye Institute | Miami | United States | 17 |
| Boston Children's Hospital | Boston | United States | 343 |
| Duke Eye Center | Durham | United States | 14 |
| Erie Retina Research, LLC | Erie | United States | 1 |
| Mississippi Retina Associates | Jackson | United States | 3 |
| Retina Consultants of Texas | Bellaire | United States | 24 |
| Retina Foundation of the Southwest | Dallas | United States | 38 |
| Retina Partners Midwest, P.C. | Carmel | United States | 2 |
| Retinal Consultants Medical Group | Sacramento | United States | 11 |
| The Retina Institute | St Louis | United States | 15 |
| Valley Retina Institute | McAllen | United States | 12 |
| Vitreo Retinal Associates, P.A. | Gainesville | United States | 1 |